J Vasc Surg ; S5A Management of peripheral arterial disease PAD. J Vasc Surg ; 31 1 part 2 : S Int Angiol ; 19 1 Suppl.
|Genre:||Health and Food|
|Published (Last):||4 December 2005|
|PDF File Size:||16.50 Mb|
|ePub File Size:||1.51 Mb|
|Price:||Free* [*Free Regsitration Required]|
Primary stenting is a well-established treatment option for femoropopliteal arterial obstructive disease. There is a shortage of Brazilian studies of the subject. To evaluate short and mid-term clinical and radiological outcomes in patients classified as Rutherford and treated with stenting of femoropopliteal lesions.
Analysis based on a prospectively populated database of patients treated from July to July The primary endpoint was primary patency. Target Vessel Revascularization, limb salvage rate and death, within a month follow-up period.
The primary patency rates at 6, 12, and 24 months were Cox regression analysis revealed lower patency rates in patients with occlusive disease hazard ratio [HR], 6. At 12 months, The limb salvage rate at 24 months was Freedom from TVR at 24 months was Results of primary patency were compatible with international studies, despite the more advanced stage of the vascular disease observed in our group.
Occlusive disease and complex lesions were both associated with worse outcomes. Entre julho de e julho de , 92 doentes foram submetidos a abordagem endovascular com implante de stent. A Tabela 1 apresenta as comorbidades dos doentes estudados.
Uma melhora de pelo menos uma categoria de DAP de Rutherford foi observada em 12 e 24 meses. A hiperplasia miointimal e a estenose intra-stent permanecem sendo o calcanhar de Aquiles da angioplastia com implante de stent.
Nossos resultados apresentaram-se conforme os descritos em grandes estudos, sendo superiores aos resultados relatados no tratamento somente com angioplastia sem implante de stent.
J Vasc Bras. Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES J Vasc Surg. Bypass versus angioplasty in severe ischaemia of the leg BASIL : multicentre, randomised controlled trial.
Angioplasty versus bypass surgery in patients with critical limb ischemia-a meta-analysis. Int J Clin Exp Med. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent. Inflammatory markers and restenosis in peripheral percutaneous angioplasty with intravascular stenting: current concepts.
Ann Vasc Surg. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. German center subanalysis of the LEVANT 2 global randomized study of the Lutonix drug-coated balloon in the treatment of femoropopliteal occlusive disease. J Endovasc Ther. Results of primary stent therapy for femoropopliteal peripheral arterial disease at 7 years.
Standards of practice for superficial femoral and popliteal artery angioplasty and stenting. Cardiovasc Intervent Radiol. Current practice of first-line treatment strategies in patients with critical limb ischemia. Is there already a place for endovascular treatment of the common femoral artery? J Cardiovasc Surg.
Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis and critical examination of current methodologies. Catheter Cardiovasc Interv. Routine stent implantation vs. Eur Heart J. Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials. Angioplasty versus bare metal stenting for superficial femoral artery lesions. Cochrane Database Syst Rev. Angioplasty or bypass for superficial femoral artery disease?
A randomised controlled trial. Eur J Vasc Endovasc Surg. Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysis. Inflammatory response to stent implantation: differences in femoropopliteal, iliac, and carotid arteries. Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: month results from the IN.
Drug-coated balloons vs. Management of peripheral arterial disease PAD. Section D: chronic critical limb ischaemia. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels: a statement for health professionals from a Special Writing Group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio-Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart Association.
J Vasc Interv Radiol. Analysis of endovascular therapy for femoropopliteal disease with the Supera stent. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. Services on Demand Journal. Abstract Background Primary stenting is a well-established treatment option for femoropopliteal arterial obstructive disease.
Objectives To evaluate short and mid-term clinical and radiological outcomes in patients classified as Rutherford and treated with stenting of femoropopliteal lesions. Methods Analysis based on a prospectively populated database of patients treated from July to July Conclusions Results of primary patency were compatible with international studies, despite the more advanced stage of the vascular disease observed in our group.
Recebido: 13 de Junho de ; Aceito: 16 de Outubro de Rua Estela, , bloco E, conj. How to cite this article.
Enfermedad arterial periférica (PAD)
2007, Número 4